TELFAST

This brand name is authorized in Australia, Croatia, Cyprus, Finland, France, Germany, Hong Kong SAR China, Ireland, Italy, Malta, Netherlands, New Zealand, Poland, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug TELFAST contains one active pharmaceutical ingredient (API):

1
UNII 2S068B75ZU - FEXOFENADINE HYDROCHLORIDE
 

Fexofenadine is a non-sedating H1 antihistamine. Fexofenadine is a pharmacologically active metabolite of terfenadine.

 
Read more about Fexofenadine

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 TELFAST Film-coated tablet MPI, EU: SmPC Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
R06AX26 Fexofenadine R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AX Other antihistamines for systemic use
Discover more medicines within R06AX26

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AU Pharmaceutical Benefits Scheme 4237B, 4238C
DE Bundesinstitut für Arzneimittel und Medizinprodukte 00018520, 00018537, 00018543, 01229638, 01229644, 01229650, 01239648, 01239654, 01239660, 01241993, 01242001, 01242018, 01242024, 01248340, 01248357, 01260482, 01260499, 01260507, 01260542, 01260559, 01260565, 01263055, 01263061, 01277258, 01277264, 01277270, 01309596, 01417601, 02160564, 02160587, 02160601, 04130952, 05126585, 05126616, 05126651, 05958110, 05958127, 05958133, 06077469, 08540291, 08540322, 08540345, 08540368, 08540374, 09686163
ES Centro de información online de medicamentos de la AEMPS 61910
FI Lääkealan turvallisuus- ja kehittämiskeskus 004955, 011552, 075069, 085969, 086108, 171000
FR Base de données publique des médicaments 63361640, 68712285
GB Medicines & Healthcare Products Regulatory Agency 19949, 19963, 381694, 381696, 47227
HK Department of Health Drug Office 44732, 44733, 60536
HR Agencija za lijekove i medicinske proizvode HR-H-099579965, HR-H-450430371
IE Health Products Regulatory Authority 48222, 48233, 48246, 48284, 48287, 48288, 48294, 48296, 48297
IT Agenzia del Farmaco 033303037, 033303049, 033303330, 033303417
MT Medicines Authority MA1470/00701, MA1470/01001, MA1470/01002, PI1438/06101A, PI1438/06102A, PI908/06801A, PI908/06802A
NL Z-Index G-Standaard, PRK 48747, 76937
NZ Medicines and Medical Devices Safety Authority 13921, 14460, 14461, 7592, 7593, 8755, 8756
PL Rejestru Produktów Leczniczych 100234048
SG Health Sciences Authority 11699P, 11704P, 14199P
TN Direction de la Pharmacie et du Médicament 5933071, 5933072
TR İlaç ve Tıbbi Cihaz Kurumu 8699809090255, 8699809090262
ZA Health Products Regulatory Authority 32/5.7.1/0446, 32/5.7.1/0447, 42/5.7.1/0339

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.